Friday, August 9, 2013

Sun Pharma replaces Cipla as the 2nd largest domestic formulation company in terms of market share in India - Reports Q1 FY-14 Financial resuts

Sun Pharmaceutical Industries Ltd. reported financials for the first quarter ending June 30th, 2013. Sun pharma generated sales of Rs. 849 crores for its branded prescription formulations in India which grew by 44% from Q1 last year, accounting for 24% of total sales. Adjusted sales growth for the quarter was 11%.

Sun Pharma is now ranked 2rd and holds 5.1% market share in the Rs.72,000 crores Indian pharmaceutical market, as per June-2013 AIOCD-AWACS report. In the previous quarter ending March 31st, Sun pharma was ranked 3rd with 4.9% market share.




Enter your email address:


Delivered by FeedBurner